/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.
Issuer: Immunic, Inc. / Key word(s): Personnel Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D. 27.04.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic, Inc. Strengthens Its Board of Directors with th.
Immunic Inc (IMUX) Appoints Richard Rudick to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Immunic Inc (NASDAQ:IMUX) has announced the appointment of Dr Richard Rudick to its board of directors, effective April 26, 2023. The biotechnology company.
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén - read this article along with other careers information, tips and advice on BioSpace